We performed a chemo-enzymatic transformation of maltooligosaccharide into both end-modified oligosyl-lactone to be of potential utility as a substrate analogue inhibitor for mammalian α-amylases. Enzymatic modification at the nonreducing end glucosyl residue of maltooligosaccharide was first carried out using the transglycosylation of β-D-galactosidase from Bacillus circulars. When maltotriose and maltotetraose were acceptors, the enzyme regioselectively synthesized 4
3-O-β-D-galactosyla-maltotriose (LG3) and 4
4-O-β-D-galactosyl-α-maltotetraose (LG4) from lactose as a donor, respectively. LG4 was further selectively hydrolyzed with specific G2-forming amylase to afford 4
2- 0-β-Dgalactosyl-α-maltose (LG2). The anomer hydroxyl groups of LG2 and LG3 were chemically oxidized to the corresponding lactones 4
2-O-β-D-galactosyl-cr-maltobionolactone (LG20) and 4
3-O- β-Dgalactosyl-α-maltotrionolactone (LG3O), respectively. LG2O and LG3O, which are competitive inhibitors for mammalian α-amylases, had K, values on the order of 1.87×10
-5-2.80×10
-6 M, using pnitrophenyl-α-maltopentaoside (G5P) as a substrate and 3.20×10
-4-1.38×10
-5 M using soluble starch. In 1H-NMR analysis, these oligonolactones were shown to exist in two forms of the lactone-ring and the open-chain form of aldonic acid in aqueous solution. In this case, the lactone form was essential for the occurrence of α-amylase inhibitor.
View full abstract